BrecherG.CronkiteE. P.PeersJ. H.: Neoplasms in rats protected against lethal doses of irradiation by parabiosis or para-aminopropriophenone. J. Nat. Cancer Inst.14 (1953), 159.
2.
DuplanJ. F.: Incidence des radioleucoses lymphoïdes chez les souris protégées contre l'effet létal des rayons X par des substances chimiques. Compt. rend. soc. biol.152 (1958), 254.
3.
HollaenderA.CongdonC. C.DohertyD. G.MakinodanT.UptonA. C.: New developments in radiation protection and recovery. Proc. of 2nd Internat. Conf. on Peaceful Uses of Atomic Energy, Geneva (1958).
4.
HollaenderA.StapletonG. E.: Studies on protection by treatment before and after exposure by X- and gamma radiationProc. Internat. Conf. on Peaceful Uses of Atomic Energy, Geneva, 1955, United Nations, New York (1956), Vol. 11, pp. 311–314.
5.
HollcroftJ.LorenzE.MillerE.CongdonC. C.SchweisthalR.UphofD.: Delayed effects in mice following acute total-body X irradiation: Modification by experimental treatment. J. Nat. Cancer Inst.18 (1957), 615.
6.
KaplanH. S.BrownM. B.: A quantitative dose-response study of lymphoidtumour development in irradiated C57 black mice. J. Nat. Cancer Inst.13 (1952), 185.
7.
KaplanH. S.BrownM. B.PaullJ.: Influence of bone marrow injections on involution and neoplasia of mouse thymus after systemic irradiation. J. Nat. Cancer Inst.14 (1953), 303.
8.
KimballA. W.: Estimation of disease incidence in populations subject to multiple causes of death. Bull. Internat. Statistical Inst. (1958). In press.
9.
LamsonB. G.MeekR. A.BennettL. R.: Late effects of total-body roentgen irradiation. II. The influence of fractionated and single radiation doses on the incidence of tumors, nephrosclerosis, and adrenal vacuolation in Wistar rats during various periods of postirradiation survival. Arch. Path.64 (1957), 505.
10.
MaisinJ.MaldagueP.DunjicA.MaisinH.: Syndromes mortels et effets tardifs des irradiations totales et subtotales chez le rat. J. belge Radiol.40 (1957), 346.
11.
MewissenD. J.BrucerM.: Late effects of gamma radiation on mice protected with cysteamine or cystamine. Nature (London)179 (1957), 201.
12.
MoleR. H.: The development of leukaemia in irradiated animals. Brit. M. Bull.14 (1958), 174.
13.
RallD. P.KellyM. G.O'GaraR. W.SchniderB. I.ZubrodC. G.: Toxicity of S,2-aminoethylisothiuronium (AET) and its effect on nitrogen mustard toxicity in normal and tumor-bearing mice. J. Pharmacol. Exper. Therap.122 (1958), 63A.
14.
ShapiraR.DohertyD. G.BurnettW. T.Jr.: Chemical protection against ionizing radiation. III. Mercaptoalkylguanidines and related isothiuronium compounds with protective activity. Radiation Res.7 (1957), 22.
15.
SmithL. H.: Protective effect of 2-mercaptoethylguanidine on bone marrow cells X-irradiated in vitro. Exper. Cell Res.13 (1957), 627.
16.
UptonA. C.ConteF. P.HurstG. S.MillsW. A.: The relative biological effectiveness of fast neutrons, X-rays, and γ-rays for acute lethality in mice. Radiation Res.4 (1956), 117.
17.
UptonA. C.WolffF. F.FurthJ.KimballA. W.: A comparison of the induction of myeloid and lymphoid leukemias in X-radiated RF mice. Cancer Res.18 (1958), 842.
18.
UrsoP.CongdonC. C.DohertyD. G.ShapiraR.: Effect of chemical protection and bone marrow treatment on radiation injury in mice. Blood13 (1958), 665.